What are the treatments for antral gastritis

Modern people's lives are extremely irregular. Not only do they go to bed late and get up late, or even stay up all night, but they also like to eat spicy and flavorful food, and drink without a limit. This has made the stomachs of many young people unbearable. Antral gastritis is a common disease, but it can affect digestion and absorption in young people. Therefore, antral gastritis needs to be taken seriously.

Antral Gastritis Overview:

Antral gastritis refers to a chronic inflammation limited to the gastric antrum. The main lesions are mostly limited to the mucosal layer, but can also spread to the muscular layer or serosa layer. Edema, inflammatory cell infiltration and fibrous tissue hyperplasia appear in the affected area, causing local thickening or even narrowing; in some cases, there may be erosion of the mucosal surface and changes in intestinal gland epithelialization. Antral gastritis is common in men over 30 years old, and is characterized by upper abdominal distension, dull pain or severe pain, which often occurs periodically and may be accompanied by belching, acid reflux, vomiting, poor appetite, weight loss, etc. Chronic antral gastritis may also manifest as anorexia, persistent abdominal pain, and hemorrhagic anemia. The treatment of antral gastritis should generally adopt measures such as diet control, sedation, acid resistance, antispasmodics, and analgesia, mainly symptomatic treatment.

Antral gastritis treatment

The treatment goals of chronic non-atrophic gastritis are to relieve indigestion symptoms and improve gastric mucosal inflammation. Treatment should be targeted at the cause as much as possible and follow the principle of individualization. No special treatment is required for patients with asymptomatic, Helicobacter pylori-negative non-atrophic gastritis.

1. About eradication of Helicobacter pylori

The main symptom of chronic non-atrophic gastritis is indigestion, which should be classified as functional dyspepsia. At present, eradication treatment is recommended both at home and abroad for functional dyspepsia caused by Helicobacter pylori. Therefore, Helicobacter pylori should be eradicated in all patients with Helicobacter pylori-positive chronic non-atrophic gastritis and dyspepsia symptoms.

2. About the treatment of indigestion symptoms

Since there is no clear relationship between clinical symptoms and chronic non-atrophic gastritis, symptomatic treatment is actually empirical treatment of functional dyspepsia. Patients with chronic gastritis and bile reflux can use prokinetic drugs (such as domperidone) and/or gastric mucosal protective agents that have the function of binding bile acid (such as aluminum carbonate preparations). For patients with gastric mucosal erosion and/or symptoms such as acid reflux and upper abdominal pain, antacids, H2 receptor antagonists or proton pump inhibitors (PPIs) can be used according to the severity of the disease or symptoms. Prokinetic drugs such as domperidone, mosapride and itopride hydrochloride can be used for patients with upper abdominal fullness, nausea or vomiting as the main symptoms. Gastric mucosal protective agents such as sucralfate, rebamipide, teprenone, gefarnate, ecabet and aluminum carbonate are suitable for people with bile reflux, gastric mucosal damage and/or obvious symptoms. Antidepressants or antianxiety drugs can be used for patients with chronic gastritis and dyspepsia symptoms with obvious psychiatric factors. Traditional Chinese medicine treatment can broaden the treatment options for chronic gastritis. In addition to their symptomatic therapeutic effects, the above-mentioned drugs may also have certain effects on gastric mucosal epithelial repair and inflammation.